Evidence map›Paper›PMID 27091392›Full record

ArticleScientific reports2016

Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.

Nao Nishida, Jun Ohashi, Seik-Soon Khor, Masaya Sugiyama, Takayo Tsuchiura, Hiromi Sawai, Keisuke Hino, Masao Honda, Shuichi Kaneko, Hiroshi Yatsuhashi and 28 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The immunogenetics of COVID-19.Immunogenetics · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 1 country.

Nao NishidaDepartment of Hepatic Disease, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
Jun OhashiDepartment of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan.
Seik-Soon KhorDepartment of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Masaya SugiyamaDepartment of Hepatic Disease, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
Takayo TsuchiuraDepartment of Hepatic Disease, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
Hiromi SawaiDepartment of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Keisuke HinoDepartment of Hepatology and Pancreatology, Kawasaki Medical School, Okayama 701-0192, Japan.
Masao HondaDepartment of Gastroenterology, Kanazawa University Graduate School of Medicine, Ishikawa 920-0942, Japan.
Shuichi KanekoDepartment of Gastroenterology, Kanazawa University Graduate School of Medicine, Ishikawa 920-0942, Japan.
Hiroshi YatsuhashiClinical Research Center, National Nagasaki Medical Center, Nagasaki 856-8562, Japan.
Osamu YokosukaDepartment of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba 263-0022, Japan.
Kazuhiko KoikeDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Masayuki KurosakiDivision of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-0023, Japan.
Namiki IzumiDivision of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo 180-0023, Japan.
Masaaki KorenagaDepartment of Hepatic Disease, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
Jong-Hon KangCenter for Gastroenterology, Teine Keijinkai Hospital, Hokkaido 006-0811, Japan.
Eiji TanakaDepartment of Medicine, Shinshu University School of Medicine, Nagano 390-0802, Japan.
Akinobu TaketomiDepartment of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Hokkaido 060-0808, Japan.
Yuichiro EguchiDivision of Hepatology, Saga Medical School, Saga 849-0937, Japan.
Naoya SakamotoDepartment of Gastroenterology and Hepatology, Hokkaido University Graduate School of Medicine, Hokkaido 060-0808, Japan.
Kazuhide YamamotoDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.
Akihiro TamoriDepartment of Hepatology, Osaka City University Graduate School of Medicine, Osaka 558-8585, Japan.
Isao SakaidaGastroenterology and Hepatology, Yamaguchi University Graduate School of Medicine, Yamaguchi 753-8511, Japan.
Shuhei HigeDepartment of Hepatology, Sapporo-Kosei General Hospital, Hokkaido 060-0033, Japan.
Yoshito ItohMolecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto 602-0841, Japan.
Satoshi MochidaDivision of Gastroenterology and Hepatology, Saitama Medical University, Saitama 350-0495, Japan.
Eiji MitaDepartment of Gastroenterology and Hepatology, National Hospital Organization Osaka National Hospital, Osaka 540-0006, Japan.
Yasuhiro TakikawaDivision of Hepatology, Department of Internal Medicine, Iwate Medical University, Iwate 020-8505, Japan.
Tatsuya IdeDivision of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Fukuoka 830-0011, Japan.
Yoichi HiasaDepartment of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan.
Hiroto KojimaHLA Foundation Laboratory, Kyoto 600-8813, Japan.
Ken YamamotoDepartment of Medical Biochemistry, Kurume University School of Medicine, Fukuoka 830-0011, Japan.
Minoru NakamuraClinical Research Center, National Nagasaki Medical Center, Nagasaki 856-8562, Japan.
Hiroh SajiHLA Foundation Laboratory, Kyoto 600-8813, Japan.
Takehiko SasazukiInstitute for Advanced Study, Kyushu University, Fukuoka 819-0395, Japan.
Tatsuya KantoDepartment of Hepatic Disease, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
Katsushi TokunagaDepartment of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Masashi MizokamiDepartment of Hepatic Disease, Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Chiba 272-8516, Japan.
National Center for Global Health and Medicine · JPThe University of Tokyo · JPHokkaido University · JPKanazawa University · JPMusashino Red Cross Hospital · JPNagasaki Medical Center · JPOkayama University · JPChiba University · JPEhime University · JPIwate Medical University · JPKawasaki Medical School · JPKurume University · JPKyoto Prefectural University of Medicine · JPKyushu University · JPOsaka City University · JPOsaka National Hospital · JPSaga Medical School Hospital · JPSaitama Medical University · JPSapporo Kosei General Hospital · JPShinshu University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Associations of variants located in the HLA class II region with chronic hepatitis B (CHB) infection have been identified in Asian populations. Here, HLA imputation method was applied to determine HLA alleles using genome-wide SNP typing data of 1,975 Japanese individuals (1,033 HBV patients and 942 healthy controls). Together with data of an additional 1,481 Japanese healthy controls, association tests of six HLA loci including HLA-A, C, B, DRB1, DQB1, and DPB1, were performed. Although the strongest association was detected at a SNP located in the HLA-DP locus in a SNP-based GWAS using data from the 1,975 Japanese individuals, HLA genotyping-based analysis identified DQB1*06:01 as having the strongest association, showing a greater association with CHB susceptibility (OR = 1.76, P = 6.57 × 10(-18)) than any one of five HLA-DPB1 alleles that were previously reported as CHB susceptibility alleles. Moreover, HLA haplotype analysis showed that, among the five previously reported HLA-DPB1 susceptibility and protective alleles, the association of two DPB1 alleles (DPB1*09:01, and *04:01) had come from linkage disequilibrium with HLA-DR-DQ haplotypes, DRB1*15:02-DQB1*06:01 and DRB1*13:02-DQB1*06:04, respectively. The present study showed an example that SNP-based GWAS does not necessarily detect the primary susceptibility locus in the HLA region.

Indexed as

Disease SusceptibilityGenotypeHaplotypesHepatitis B, ChronicHLA AntigensHumansLinkage DisequilibriumPolymorphism, Single NucleotideHLA Antigens

Identifiers

PMID27091392
PMCPMC4835786
OpenAlexW2339285910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.